<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1993-10-01" modified="2017-04-12" version="172">
<accession>P33076</accession>
<accession>A0N0N9</accession>
<accession>D3DUG0</accession>
<accession>E9PFE0</accession>
<accession>Q29675</accession>
<accession>Q8SNB8</accession>
<accession>Q96KL4</accession>
<name>C2TA_HUMAN</name>
<protein>
<recommendedName>
<fullName>MHC class II transactivator</fullName>
<shortName>CIITA</shortName>
<ecNumber>2.3.1.-</ecNumber>
<ecNumber>2.7.11.1</ecNumber>
</recommendedName>
</protein>
<gene>
<name type="primary">CIITA</name>
<name type="synonym">MHC2TA</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="Cell" volume="75" first="135" last="146">
<title>Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome).</title>
<authorList>
<person name="Steimle V."/>
<person name="Otten L.A."/>
<person name="Zufferey M."/>
<person name="Mach B."/>
</authorList>
<dbReference type="PubMed" id="8402893"/>
<dbReference type="DOI" id="10.1016/S0092-8674(05)80090-X"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANTS BLS2 LYS-120 DEL ILE-GLU INS AND 940-THR--ALA-963 DEL</scope>
<scope>VARIANTS GLY-174; ALA-500 AND ARG-900</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1995" name="Immunity" volume="2" first="533" last="543">
<title>Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA).</title>
<authorList>
<person name="Riley J.L."/>
<person name="Westerheide S.D."/>
<person name="Price J.A."/>
<person name="Brown J.A."/>
<person name="Boss J.M."/>
</authorList>
<dbReference type="PubMed" id="7749984"/>
<dbReference type="DOI" id="10.1016/1074-7613(95)90033-0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>VARIANTS BLS2 LYS-120 DEL ILE-GLU INS; GLY-174; ALA-500 AND ARG-900</scope>
<scope>ALTERNATIVE SPLICING</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2003" name="Eur. J. Immunogenet." volume="30" first="259" last="270">
<title>Structural and functional characteristics of a dominant-negative isoform of porcine MHC class II transactivator.</title>
<authorList>
<person name="Quinn G."/>
<person name="Bower R."/>
<person name="Dos-Santos Cruz G."/>
<person name="Giovino M."/>
<person name="Xu Y."/>
<person name="Patience C."/>
<person name="Schuurman H.J."/>
</authorList>
<dbReference type="PubMed" id="12919287"/>
<dbReference type="DOI" id="10.1046/j.1365-2370.2003.00397.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
<scope>VARIANT ARG-900</scope>
<scope>ALTERNATIVE SPLICING</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2003" name="Leuk. Res." volume="27" first="1027" last="1038">
<title>K-562 cells lack MHC class II expression due to an alternatively spliced CIITA transcript with a truncated coding region.</title>
<authorList>
<person name="Day N.E."/>
<person name="Ugai H."/>
<person name="Yokoyama K.K."/>
<person name="Ichiki A.T."/>
</authorList>
<dbReference type="PubMed" id="12859996"/>
<dbReference type="DOI" id="10.1016/S0145-2126(03)00072-9"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4)</scope>
<scope>VARIANTS GLY-174 AND ALA-500</scope>
<scope>ALTERNATIVE SPLICING</scope>
</reference>
<reference key="5">
<citation type="submission" date="2006-10" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Livingston R.J."/>
<person name="Shaffer T."/>
<person name="McFarland I."/>
<person name="Nguyen C.P."/>
<person name="Stanaway I.B."/>
<person name="Rajkumar N."/>
<person name="Johnson E.J."/>
<person name="da Ponte S.H."/>
<person name="Willa H."/>
<person name="Ahearn M.O."/>
<person name="Bertucci C."/>
<person name="Acklestad J."/>
<person name="Carroll A."/>
<person name="Swanson J."/>
<person name="Gildersleeve H.I."/>
<person name="Nickerson D.A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS GLY-174 AND ARG-900</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Nature" volume="432" first="988" last="994">
<title>The sequence and analysis of duplication-rich human chromosome 16.</title>
<authorList>
<person name="Martin J."/>
<person name="Han C."/>
<person name="Gordon L.A."/>
<person name="Terry A."/>
<person name="Prabhakar S."/>
<person name="She X."/>
<person name="Xie G."/>
<person name="Hellsten U."/>
<person name="Chan Y.M."/>
<person name="Altherr M."/>
<person name="Couronne O."/>
<person name="Aerts A."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Blumer H."/>
<person name="Branscomb E."/>
<person name="Brown N.C."/>
<person name="Bruno W.J."/>
<person name="Buckingham J.M."/>
<person name="Callen D.F."/>
<person name="Campbell C.S."/>
<person name="Campbell M.L."/>
<person name="Campbell E.W."/>
<person name="Caoile C."/>
<person name="Challacombe J.F."/>
<person name="Chasteen L.A."/>
<person name="Chertkov O."/>
<person name="Chi H.C."/>
<person name="Christensen M."/>
<person name="Clark L.M."/>
<person name="Cohn J.D."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Dickson M."/>
<person name="Dimitrijevic-Bussod M."/>
<person name="Escobar J."/>
<person name="Fawcett J.J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Goodstein D."/>
<person name="Goodwin L.A."/>
<person name="Grady D.L."/>
<person name="Grigoriev I."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Hildebrand C.E."/>
<person name="Huang W."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Jewett P.B."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Krawczyk M.-C."/>
<person name="Leyba T."/>
<person name="Longmire J.L."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Lowry S."/>
<person name="Ludeman T."/>
<person name="Manohar C.F."/>
<person name="Mark G.A."/>
<person name="McMurray K.L."/>
<person name="Meincke L.J."/>
<person name="Morgan J."/>
<person name="Moyzis R.K."/>
<person name="Mundt M.O."/>
<person name="Munk A.C."/>
<person name="Nandkeshwar R.D."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Predki P."/>
<person name="Parson-Quintana B."/>
<person name="Ramirez L."/>
<person name="Rash S."/>
<person name="Retterer J."/>
<person name="Ricke D.O."/>
<person name="Robinson D.L."/>
<person name="Rodriguez A."/>
<person name="Salamov A."/>
<person name="Saunders E.H."/>
<person name="Scott D."/>
<person name="Shough T."/>
<person name="Stallings R.L."/>
<person name="Stalvey M."/>
<person name="Sutherland R.D."/>
<person name="Tapia R."/>
<person name="Tesmer J.G."/>
<person name="Thayer N."/>
<person name="Thompson L.S."/>
<person name="Tice H."/>
<person name="Torney D.C."/>
<person name="Tran-Gyamfi M."/>
<person name="Tsai M."/>
<person name="Ulanovsky L.E."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="White P.S."/>
<person name="Williams A.L."/>
<person name="Wills P.L."/>
<person name="Wu J.-R."/>
<person name="Wu K."/>
<person name="Yang J."/>
<person name="DeJong P."/>
<person name="Bruce D."/>
<person name="Doggett N.A."/>
<person name="Deaven L."/>
<person name="Schmutz J."/>
<person name="Grimwood J."/>
<person name="Richardson P."/>
<person name="Rokhsar D.S."/>
<person name="Eichler E.E."/>
<person name="Gilna P."/>
<person name="Lucas S.M."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
<person name="Pennacchio L.A."/>
</authorList>
<dbReference type="PubMed" id="15616553"/>
<dbReference type="DOI" id="10.1038/nature03187"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1999" name="Science" volume="285" first="1402" last="1405">
<title>GTP binding by class II transactivator: role in nuclear import.</title>
<authorList>
<person name="Harton J.A."/>
<person name="Cressman D.E."/>
<person name="Chin K.C."/>
<person name="Der C.J."/>
<person name="Ting J.P."/>
</authorList>
<dbReference type="PubMed" id="10464099"/>
<dbReference type="DOI" id="10.1126/science.285.5432.1402"/>
</citation>
<scope>GTP-BINDING</scope>
<scope>MUTAGENESIS OF 420-GLY-LYS-421 AND ASP-561</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2001" name="Mol. Cell" volume="7" first="105" last="115">
<title>Transcriptional coactivator, CIITA, is an acetyltransferase that bypasses a promoter requirement for TAF(II)250.</title>
<authorList>
<person name="Raval A."/>
<person name="Howcroft T.K."/>
<person name="Weissman J.D."/>
<person name="Kirshner S."/>
<person name="Zhu X.S."/>
<person name="Yokoyama K."/>
<person name="Ting J."/>
<person name="Singer D.S."/>
</authorList>
<dbReference type="PubMed" id="11172716"/>
<dbReference type="DOI" id="10.1016/S1097-2765(01)00159-9"/>
</citation>
<scope>FUNCTION AS ACETYLTRANSFERASE</scope>
<scope>GTP-BINDING</scope>
<scope>ACETYLTRANSFERASE REGION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2007" name="J. Mol. Biol." volume="369" first="1175" last="1187">
<title>The zinc finger proteins ZXDA and ZXDC form a complex that binds CIITA and regulates MHC II gene transcription.</title>
<authorList>
<person name="Al-Kandari W."/>
<person name="Koneni R."/>
<person name="Navalgund V."/>
<person name="Aleksandrova A."/>
<person name="Jambunathan S."/>
<person name="Fontes J.D."/>
</authorList>
<dbReference type="PubMed" id="17493635"/>
<dbReference type="DOI" id="10.1016/j.jmb.2007.04.033"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ZXDA AND ZXDC</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2007" name="Mol. Immunol." volume="44" first="311" last="321">
<title>ZXDC, a novel zinc finger protein that binds CIITA and activates MHC gene transcription.</title>
<authorList>
<person name="Al-Kandari W."/>
<person name="Jambunathan S."/>
<person name="Navalgund V."/>
<person name="Koneni R."/>
<person name="Freer M."/>
<person name="Parimi N."/>
<person name="Mudhasani R."/>
<person name="Fontes J.D."/>
</authorList>
<dbReference type="PubMed" id="16600381"/>
<dbReference type="DOI" id="10.1016/j.molimm.2006.02.029"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ZXDC</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2012" name="J. Cell Biol." volume="199" first="49" last="63">
<title>PML promotes MHC class II gene expression by stabilizing the class II transactivator.</title>
<authorList>
<person name="Ulbricht T."/>
<person name="Alzrigat M."/>
<person name="Horch A."/>
<person name="Reuter N."/>
<person name="von Mikecz A."/>
<person name="Steimle V."/>
<person name="Schmitt E."/>
<person name="Kraemer O.H."/>
<person name="Stamminger T."/>
<person name="Hemmerich P."/>
</authorList>
<dbReference type="PubMed" id="23007646"/>
<dbReference type="DOI" id="10.1083/jcb.201112015"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PML</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2013" name="Biochim. Biophys. Acta" volume="1829" first="1184" last="1190">
<title>Transcriptional coactivator CIITA, a functional homolog of TAF1, has kinase activity.</title>
<authorList>
<person name="Soe K.C."/>
<person name="Devaiah B.N."/>
<person name="Singer D.S."/>
</authorList>
<dbReference type="PubMed" id="24036077"/>
<dbReference type="DOI" id="10.1016/j.bbagrm.2013.09.001"/>
</citation>
<scope>FUNCTION AS KINASE</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOPHOSPHORYLATION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1999" name="Immunogenetics" volume="49" first="957" last="963">
<title>Absence of MHC class II gene expression in a patient with a single amino acid substitution in the class II transactivator protein CIITA.</title>
<authorList>
<person name="Quan V."/>
<person name="Towey M."/>
<person name="Sacks S."/>
<person name="Kelly A.P."/>
</authorList>
<dbReference type="PubMed" id="10501838"/>
<dbReference type="DOI" id="10.1007/s002510050579"/>
</citation>
<scope>VARIANT BLS2 GROUP A SER-962</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2001" name="J. Immunol." volume="167" first="1787" last="1794">
<title>Mutation in the class II trans-activator leading to a mild immunodeficiency.</title>
<authorList>
<person name="Wiszniewski W."/>
<person name="Fondaneche M.-C."/>
<person name="Le Deist F."/>
<person name="Kanariou M."/>
<person name="Selz F."/>
<person name="Brousse N."/>
<person name="Steimle V."/>
<person name="Barbieri G."/>
<person name="Alcaide-Loridan C."/>
<person name="Charron D."/>
<person name="Fischer A."/>
<person name="Lisowska-Grospierre B."/>
</authorList>
<dbReference type="PubMed" id="11466404"/>
<dbReference type="DOI" id="10.4049/jimmunol.167.3.1787"/>
</citation>
<scope>VARIANT BLS2 GROUP A PRO-469</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2002" name="J. Immunol." volume="169" first="607" last="607">
<authorList>
<person name="Wiszniewski W."/>
<person name="Fondaneche M.-C."/>
<person name="Le Deist F."/>
<person name="Kanariou M."/>
<person name="Selz F."/>
<person name="Brousse N."/>
<person name="Steimle V."/>
<person name="Barbieri G."/>
<person name="Alcaide-Loridan C."/>
<person name="Charron D."/>
<person name="Fischer A."/>
<person name="Lisowska-Grospierre B."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2002" name="Immunogenetics" volume="53" first="821" last="829">
<title>Three novel mutations of the CIITA gene in MHC class II-deficient patients with a severe immunodeficiency.</title>
<authorList>
<person name="Dziembowska M."/>
<person name="Fondaneche M.-C."/>
<person name="Vedrenne J."/>
<person name="Barbieri G."/>
<person name="Wiszniewski W."/>
<person name="Picard C."/>
<person name="Cant A.J."/>
<person name="Steimle V."/>
<person name="Charron D."/>
<person name="Alcaide-Loridan C."/>
<person name="Fischer A."/>
<person name="Lisowska-Grospierre B."/>
</authorList>
<dbReference type="PubMed" id="11862382"/>
<dbReference type="DOI" id="10.1007/s00251-001-0395-7"/>
</citation>
<scope>VARIANTS BLS2 GROUP A 964-LEU--ASP-991 DEL AND ILE-1027 DEL</scope>
</reference>
<comment type="function">
<text evidence="4 9 10 12">Essential for transcriptional activity of the HLA class II promoter; activation is via the proximal promoter. No DNA binding of in vitro translated CIITA was detected. May act in a coactivator-like fashion through protein-protein interactions by contacting factors binding to the proximal MHC class II promoter, to elements of the transcription machinery, or both. Alternatively it may activate HLA class II transcription by modifying proteins that bind to the MHC class II promoter. Also mediates enhanced MHC class I transcription; the promoter element requirements for CIITA-mediated transcription are distinct from those of constitutive MHC class I transcription, and CIITA can functionally replace TAF1 at these genes. Exhibits intrinsic GTP-stimulated acetyltransferase activity. Exhibits serine/threonine protein kinase activity: can phosphorylate the TFIID component TAF7, the RAP74 subunit of the general transcription factor TFIIF, histone H2B at 'Ser-37' and other histones (in vitro).</text>
</comment>
<comment type="catalytic activity">
<text evidence="12">ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="subunit">
<text evidence="9 10 11">Interacts with ZXDA and ZXDC. Interacts with PML (isoform PML-2).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1538819"/>
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
<label>SIRT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1538819"/>
<interactant intactId="EBI-1538980">
<id>P98168</id>
<label>ZXDA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1538819"/>
<interactant intactId="EBI-1538838">
<id>Q2QGD7</id>
<label>ZXDC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="11">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="11">Nucleus</location>
<location evidence="11">PML body</location>
</subcellularLocation>
<text>Recruited to PML body by PML.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P33076-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P33076-2</id>
<name>2</name>
<sequence type="described" ref="VSP_055099 VSP_055102 VSP_055103"/>
</isoform>
<isoform>
<id>P33076-3</id>
<name>3</name>
<name>hCIITA'</name>
<sequence type="described" ref="VSP_055099 VSP_055100 VSP_055101"/>
<text>Exhibits dominant-negative suppression of MHC class II gene expression.</text>
</isoform>
<isoform>
<id>P33076-4</id>
<name>4</name>
<sequence type="described" ref="VSP_055102 VSP_055103"/>
</isoform>
</comment>
<comment type="domain">
<text>The acetyltransferase domain is necessary for activation of both class I and class II transcription.</text>
</comment>
<comment type="domain">
<text>The GTP-binding motif doesn't confer GTPase activity but promotes nuclear localization.</text>
</comment>
<comment type="PTM">
<text>Autophosphorylated, affecting interaction with TAF7.</text>
</comment>
<comment type="disease" evidence="3 5 6 13 14">
<disease id="DI-00171">
<name>Bare lymphocyte syndrome 2</name>
<acronym>BLS2</acronym>
<description>A severe combined immunodeficiency disease with early onset. It is characterized by a profound defect in constitutive and interferon-gamma induced MHC II expression, absence of cellular and humoral T-cell response to antigen challenge, hypogammaglobulinemia and impaired antibody production. The consequence include extreme susceptibility to viral, bacterial and fungal infections.</description>
<dbReference type="MIM" id="209920"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="online information" name="CIITAbase">
<link uri="http://structure.bmc.lu.se/idbase/CIITAbase/"/>
<text>CIITA mutation db</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/MHC2TAID260.html"/>
</comment>
<dbReference type="EC" id="2.3.1.-"/>
<dbReference type="EC" id="2.7.11.1"/>
<dbReference type="EMBL" id="X74301">
<property type="protein sequence ID" value="CAA52354.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U18259">
<property type="protein sequence ID" value="AAA88861.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U18288">
<property type="protein sequence ID" value="AAA88862.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY084054">
<property type="protein sequence ID" value="AAM15723.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF410154">
<property type="protein sequence ID" value="AAL04118.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF064747">
<property type="protein sequence ID" value="ABK41930.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC133065">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471112">
<property type="protein sequence ID" value="EAW85169.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471112">
<property type="protein sequence ID" value="EAW85172.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471112">
<property type="protein sequence ID" value="EAW85173.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS10544.1">
<molecule id="P33076-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS66943.1">
<molecule id="P33076-3"/>
</dbReference>
<dbReference type="PIR" id="A48843">
<property type="entry name" value="A48843"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000237.2">
<property type="nucleotide sequence ID" value="NM_000246.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001273332.1">
<molecule id="P33076-3"/>
<property type="nucleotide sequence ID" value="NM_001286403.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.592051"/>
<dbReference type="UniGene" id="Hs.701991"/>
<dbReference type="ProteinModelPortal" id="P33076"/>
<dbReference type="SMR" id="P33076"/>
<dbReference type="BioGrid" id="110416">
<property type="interactions" value="24"/>
</dbReference>
<dbReference type="IntAct" id="P33076">
<property type="interactions" value="3"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000316328"/>
<dbReference type="iPTMnet" id="P33076"/>
<dbReference type="PhosphoSitePlus" id="P33076"/>
<dbReference type="BioMuta" id="CIITA"/>
<dbReference type="DMDM" id="317373472"/>
<dbReference type="MaxQB" id="P33076"/>
<dbReference type="PaxDb" id="P33076"/>
<dbReference type="PeptideAtlas" id="P33076"/>
<dbReference type="PRIDE" id="P33076"/>
<dbReference type="DNASU" id="4261"/>
<dbReference type="Ensembl" id="ENST00000381835">
<molecule id="P33076-3"/>
<property type="protein sequence ID" value="ENSP00000371257"/>
<property type="gene ID" value="ENSG00000179583"/>
</dbReference>
<dbReference type="GeneID" id="4261"/>
<dbReference type="KEGG" id="hsa:4261"/>
<dbReference type="UCSC" id="uc002dak.5">
<molecule id="P33076-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="4261"/>
<dbReference type="DisGeNET" id="4261"/>
<dbReference type="GeneCards" id="CIITA"/>
<dbReference type="HGNC" id="HGNC:7067">
<property type="gene designation" value="CIITA"/>
</dbReference>
<dbReference type="HPA" id="CAB016084"/>
<dbReference type="MalaCards" id="CIITA"/>
<dbReference type="MIM" id="209920">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="600005">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P33076"/>
<dbReference type="OpenTargets" id="ENSG00000179583"/>
<dbReference type="Orphanet" id="572">
<property type="disease" value="Immunodeficiency by defective expression of HLA class 2"/>
</dbReference>
<dbReference type="PharmGKB" id="PA30795"/>
<dbReference type="eggNOG" id="KOG4308">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410ZBX3">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00860000133673"/>
<dbReference type="HOGENOM" id="HOG000107439"/>
<dbReference type="HOVERGEN" id="HBG000174"/>
<dbReference type="InParanoid" id="P33076"/>
<dbReference type="KO" id="K08060"/>
<dbReference type="PhylomeDB" id="P33076"/>
<dbReference type="TreeFam" id="TF352118"/>
<dbReference type="Reactome" id="R-HSA-877300">
<property type="pathway name" value="Interferon gamma signaling"/>
</dbReference>
<dbReference type="SIGNOR" id="P33076"/>
<dbReference type="GeneWiki" id="CIITA"/>
<dbReference type="GenomeRNAi" id="4261"/>
<dbReference type="PRO" id="PR:P33076"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 16"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000179583"/>
<dbReference type="CleanEx" id="HS_CIITA"/>
<dbReference type="ExpressionAtlas" id="P33076">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016605">
<property type="term" value="C:PML body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033613">
<property type="term" value="F:activating transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005525">
<property type="term" value="F:GTP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016301">
<property type="term" value="F:kinase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0008022">
<property type="term" value="F:protein C-terminus binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032403">
<property type="term" value="F:protein complex binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0044212">
<property type="term" value="F:transcription regulatory region DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016746">
<property type="term" value="F:transferase activity, transferring acyl groups"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006955">
<property type="term" value="P:immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0060333">
<property type="term" value="P:interferon-gamma-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0032966">
<property type="term" value="P:negative regulation of collagen biosynthetic process"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045345">
<property type="term" value="P:positive regulation of MHC class I biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045348">
<property type="term" value="P:positive regulation of MHC class II biosynthetic process"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046677">
<property type="term" value="P:response to antibiotic"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0034341">
<property type="term" value="P:response to interferon-gamma"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="InterPro" id="IPR001611">
<property type="entry name" value="Leu-rich_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR008095">
<property type="entry name" value="MHC_II_transact"/>
</dbReference>
<dbReference type="InterPro" id="IPR007111">
<property type="entry name" value="NACHT_NTPase"/>
</dbReference>
<dbReference type="InterPro" id="IPR027417">
<property type="entry name" value="P-loop_NTPase"/>
</dbReference>
<dbReference type="Pfam" id="PF13516">
<property type="entry name" value="LRR_6"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PRINTS" id="PR01719">
<property type="entry name" value="MHCIIACTVATR"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52540">
<property type="entry name" value="SSF52540"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51450">
<property type="entry name" value="LRR"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PROSITE" id="PS50837">
<property type="entry name" value="NACHT"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0012">Acyltransferase</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0342">GTP-binding</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0433">Leucine-rich repeat</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0705">SCID</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<feature type="chain" description="MHC class II transactivator" id="PRO_0000089241">
<location>
<begin position="1"/>
<end position="1130"/>
</location>
</feature>
<feature type="domain" description="NACHT" evidence="1">
<location>
<begin position="414"/>
<end position="724"/>
</location>
</feature>
<feature type="repeat" description="LRR 1">
<location>
<begin position="985"/>
<end position="1008"/>
</location>
</feature>
<feature type="repeat" description="LRR 2">
<location>
<begin position="1016"/>
<end position="1037"/>
</location>
</feature>
<feature type="repeat" description="LRR 3">
<location>
<begin position="1045"/>
<end position="1066"/>
</location>
</feature>
<feature type="repeat" description="LRR 4">
<location>
<begin position="1073"/>
<end position="1093"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="GTP">
<location>
<begin position="420"/>
<end position="427"/>
</location>
</feature>
<feature type="region of interest" description="Required for acetyltransferase activity">
<location>
<begin position="94"/>
<end position="132"/>
</location>
</feature>
<feature type="compositionally biased region" description="Asp/Glu-rich (acidic)">
<location>
<begin position="52"/>
<end position="137"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 3." id="VSP_055099" evidence="17 18">
<original>AEPPTVVTGSLLVRPVSDCSTLPCLPLPALFNQEPASGQMRLEKTDQIPM</original>
<variation>V</variation>
<location>
<begin position="161"/>
<end position="210"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_055100" evidence="17">
<original>EPVEQFYRSLQDTYG</original>
<variation>GLAWSPCLGLRPSLH</variation>
<location>
<begin position="336"/>
<end position="350"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_055101" evidence="17">
<location>
<begin position="351"/>
<end position="885"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 4." id="VSP_055102" evidence="16 18">
<original>AALSDTVALWESLQQHGETKLLQAAEEKFTIEPFKAKSLKDVED</original>
<variation>WGEGLGRDILVLGINCGLGAKPSALWGPFSMQSSRVGQNGFSPF</variation>
<location>
<begin position="887"/>
<end position="930"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 4." id="VSP_055103" evidence="16 18">
<location>
<begin position="931"/>
<end position="1128"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2229317." id="VAR_029270">
<original>L</original>
<variation>V</variation>
<location>
<position position="45"/>
</location>
</feature>
<feature type="sequence variant" description="In BLS2." id="VAR_005127">
<original>K</original>
<variation>IE</variation>
<location>
<position position="120"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs8046121." id="VAR_047907" evidence="7 13 14 15">
<original>R</original>
<variation>G</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="sequence variant" description="In BLS2; mild immunodeficiency; has residual MHC class II trans activation activity." id="VAR_015551" evidence="5">
<original>L</original>
<variation>P</variation>
<location>
<position position="469"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4774." id="VAR_005128" evidence="7 13 14">
<original>G</original>
<variation>A</variation>
<location>
<position position="500"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2229319." id="VAR_015552">
<original>A</original>
<variation>G</variation>
<location>
<position position="658"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs13330686." id="VAR_060104">
<original>S</original>
<variation>L</variation>
<location>
<position position="781"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs13336804." id="VAR_057711">
<original>V</original>
<variation>A</variation>
<location>
<position position="782"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs7197779." id="VAR_047908" evidence="8 13 14 15">
<original>Q</original>
<variation>R</variation>
<location>
<position position="900"/>
</location>
</feature>
<feature type="sequence variant" description="In BLS2." id="VAR_005129" evidence="14">
<location>
<begin position="940"/>
<end position="963"/>
</location>
</feature>
<feature type="sequence variant" description="In BLS2." id="VAR_015553" evidence="3">
<original>F</original>
<variation>S</variation>
<location>
<position position="962"/>
</location>
</feature>
<feature type="sequence variant" description="In BLS2." id="VAR_015554">
<location>
<begin position="964"/>
<end position="991"/>
</location>
</feature>
<feature type="sequence variant" description="In BLS2." id="VAR_015555" evidence="6">
<location>
<position position="1027"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces GTP-binding and abolishes transactivation at MHC promoters." evidence="2">
<location>
<begin position="420"/>
<end position="421"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces GTP-binding and abolishes transactivation at MHC promoters." evidence="2">
<original>D</original>
<variation>A</variation>
<location>
<position position="561"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; ABK41930." ref="4" evidence="19">
<original>LN</original>
<variation>RS</variation>
<location>
<begin position="1020"/>
<end position="1021"/>
</location>
</feature>
<evidence key="1" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00136"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10464099"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10501838"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11172716"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11466404"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11862382"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12859996"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12919287"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16600381"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17493635"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23007646"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24036077"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7749984"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8402893"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source ref="5"/>
</evidence>
<evidence key="16" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="12859996"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="12919287"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7749984"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000305"/>
<sequence length="1130" mass="123514" checksum="7A61CAA4F3FFECE0" modified="2011-01-11" version="3">
MRCLAPRPAGSYLSEPQGSSQCATMELGPLEGGYLELLNSDADPLCLYHFYDQMDLAGEE
EIELYSEPDTDTINCDQFSRLLCDMEGDEETREAYANIAELDQYVFQDSQLEGLSKDIFK
HIGPDEVIGESMEMPAEVGQKSQKRPFPEELPADLKHWKPAEPPTVVTGSLLVRPVSDCS
TLPCLPLPALFNQEPASGQMRLEKTDQIPMPFSSSSLSCLNLPEGPIQFVPTISTLPHGL
WQISEAGTGVSSIFIYHGEVPQASQVPPPSGFTVHGLPTSPDRPGSTSPFAPSATDLPSM
PEPALTSRANMTEHKTSPTQCPAAGEVSNKLPKWPEPVEQFYRSLQDTYGAEPAGPDGIL
VEVDLVQARLERSSSKSLERELATPDWAERQLAQGGLAEVLLAAKEHRRPRETRVIAVLG
KAGQGKSYWAGAVSRAWACGRLPQYDFVFSVPCHCLNRPGDAYGLQDLLFSLGPQPLVAA
DEVFSHILKRPDRVLLILDGFEELEAQDGFLHSTCGPAPAEPCSLRGLLAGLFQKKLLRG
CTLLLTARPRGRLVQSLSKADALFELSGFSMEQAQAYVMRYFESSGMTEHQDRALTLLRD
RPLLLSHSHSPTLCRAVCQLSEALLELGEDAKLPSTLTGLYVGLLGRAALDSPPGALAEL
AKLAWELGRRHQSTLQEDQFPSADVRTWAMAKGLVQHPPRAAESELAFPSFLLQCFLGAL
WLALSGEIKDKELPQYLALTPRKKRPYDNWLEGVPRFLAGLIFQPPARCLGALLGPSAAA
SVDRKQKVLARYLKRLQPGTLRARQLLELLHCAHEAEEAGIWQHVVQELPGRLSFLGTRL
TPPDAHVLGKALEAAGQDFSLDLRSTGICPSGLGSLVGLSCVTRFRAALSDTVALWESLQ
QHGETKLLQAAEEKFTIEPFKAKSLKDVEDLGKLVQTQRTRSSSEDTAGELPAVRDLKKL
EFALGPVSGPQAFPKLVRILTAFSSLQHLDLDALSENKIGDEGVSQLSATFPQLKSLETL
NLSQNNITDLGAYKLAEALPSLAASLLRLSLYNNCICDVGAESLARVLPDMVSLRVMDVQ
YNKFTAAGAQQLAASLRRCPHVETLAMWTPTIPFSVQEHLQQQDSRISLR
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>